David Palma, MD, PhD
@drdavidpalma
Radiation Oncologist | Researcher | Marathon runner and triathlete | Dad x 3 | Author, Taking Charge of Cancer
Great thread about Advanced Practice RTTs. In 🇨🇦 they are game changers! Roles include consenting, ordering RT, contouring, leading QA rounds, attending setup at the unit, approving re-plans, and running RCTs! They make our team stronger. Feel free to message me if questions.
Is it time to rethink the role of the RTT in U.S. #RadOnc? What is an Advanced Practice Radiation Therapist (APRT)? Globally, APRTs are stepping into expanded roles—but in the U.S., that concept doesn’t yet exist. Should it? Let’s break it down. 🧵 #RadiationTherapy #APRT 1/7
Is it time to rethink the role of the RTT in U.S. #RadOnc? What is an Advanced Practice Radiation Therapist (APRT)? Globally, APRTs are stepping into expanded roles—but in the U.S., that concept doesn’t yet exist. Should it? Let’s break it down. 🧵 #RadiationTherapy #APRT 1/7
Friendly reminder: the deadline for the Red Journal SBRT issue is June 30. It's shaping up to be an excellent issue, with more than 100 submissions already. redjournal.org
Our newest CAPRI trial, called PREVENT, is a phase II/III RCT testing high dose palliative RT for NSCLC to dose of 35/5, with esophageal sparing. 🇨🇦 We hope this will improve survival and QOL. Congrats @goodmanC_MD for getting this off the ground! ⬇️⬇️⬇️
Thrilled to activate PREVENT! This phase II/III RCT builds on the success of @DrAlexLouie's PROACTIVE trial by randomizing patients requiring palliative thoracic RT 2:1 to high-dose esophageal-sparing vs. traditional palliation to a max dose of 30 Gy in 10 equivalent
A gift from a patient today. It’s a painted rock with the slogan from his airborne division. He says it would be a good slogan for #radonc too. “Strike with a sure hand” ⚡️⚡️⚡️
Great paper on unilateral vs. bilateral TORS for tonsillar SCC, featured in @QuadShotNews Contralateral tonsillar primaries: <2%. Post-op bleeding rate: 7% unilateral vs. 15% bilateral G-tube rate at last follow-up: 8% Peri-op MDADI scores: fell from high 80's to mid 70's.
Agree. Titles in scientific journals should not replicate click-bait approaches that have taken over journalism.
Thanks Ralph. I admire your work & I have no issues with the paper. My point is that we need accurate titles & abstracts. Things go viral. Most don't read the paper. Defending the title/abstract by saying that the whole paper says something different just reinforces my point.
#SABR2025 registrations are open #radonc!! sabrsymposium.com - Come join us @PeterMacCC @PeterMacRadOnc on Nov 14th-15th. We have a phenomenal international faculty line up 🇺🇸🇨🇦🇮🇹🇫🇷🇦🇺with @PBlanchardMD @lauren_henke, @BarbaraJereczek, @DrewMoghanaki and @Melissa_O_Neil.…
🚨📢🌟 CURB2 Ph3 Trial is activated by @NCICTEP_ClinRes (NCT06686771), built upon CURB Ph2 RCT @TheLancet/@MSKCancerCenter. Appreciate the support of @NRGonc/@SWOG/@CCTG. Pls contact us for activation at your local site❗️ @pmcancercentre @ldawsonmd @DrAlexLouie @HoudaBahig